Risk from Lithium with Acetylcholinesterase Inhibitor

Author： Amante A.A.  

Publisher： Springer Publishing Company

ISSN： 1040-1237

Source： Annals of Clinical Psychiatry (after Jan 1, 2004), Vol.14, Iss.4, 2002-12, pp. : 253-253

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The BRAINz trial: a novel approach to acetylcholinesterase-inhibitor treatment for Alzheimer’s disease

By Wilkinson David   Roughan Laura  

Future Neurology, Vol. 2, Iss. 4, 2007-07 ,pp. : 379-382

Future Medicine

Access to resources Recommend Favorite

An Overview of Phenserine Tartrate, A Novel Acetylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 2, Iss. 3, 2005-07 ,pp. : 281-290

Bentham Science Publishers

Access to resources Recommend Favorite

Potentiation effects of (+/-)huprine X, a new acetylcholinesterase inhibitor, on nicotinic receptors in rat cortical synaptosomes

By Roman S.   Badia A.   Camps P.   Clos M.V.  

Neuropharmacology, Vol. 46, Iss. 1, 2004-01 ,pp. : 95-102

Elsevier

Access to resources Recommend Favorite

Gene transfer of acetylcholinesterase protects the knockout mouse from the toxicity of DFP

By Li Bin   Duysen Ellen   Lockridge Oksana  

Journal of Molecular Neuroscience, Vol. 30, Iss. 1-2, 2006-02 ,pp. : 79-80

Humana Press, Inc

Access to resources Recommend Favorite

Bioactivity of a peptide derived from acetylcholinesterase in hippocampal organotypic cultures

By Day T.   Greenfield S.  

Experimental Brain Research, Vol. 155, Iss. 4, 2004-04 ,pp. : 500-508

Springer Publishing Company

Access to resources Recommend Favorite